Visual symptoms in Parkinson's disease and Parkinson's disease dementia

Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cognitive decline,...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 26; no. 13; pp. 2387 - 2395
Main Authors Archibald, Neil K., Clarke, Mike P., Mosimann, Urs P., Burn, David J.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.2011
Wiley
Subjects
Online AccessGet full text
ISSN0885-3185
1531-8257
1531-8257
DOI10.1002/mds.23891

Cover

Abstract Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cognitive decline, visual impairment, and other visual symptoms remains poorly understood. Our aim was to characterize the spectrum of visual symptomatology in PD and examine clinical predictors for their occurrence. Sixty‐four subjects with PD, 26 with PD dementia, and 32 age‐matched controls were assessed for visual symptoms, cognitive impairment, and ocular pathology. Complex visual hallucinations were common in PD (17%) and PD dementia (89%). Dementia subjects reported illusions (65%) and presence (62%) more frequently than PD or control subjects, but the frequency of passage hallucinations in PD and PD dementia groups was equivalent (48% versus 69%, respectively; P = 0.102). Visual acuity and contrast sensitivity was impaired in parkinsonian subjects, with disease severity and age emerging as the key predictors. Regression analysis identified a variety of factors independently predictive of complex visual hallucinations (e.g., dementia, visual acuity, and depression), illusions (e.g., excessive daytime somnolence and disease severity), and presence (e.g., rapid eye movement sleep behavior disorder and excessive daytime somnolence). Our results demonstrate that different “hallucinatory” experiences in PD do not necessarily share common disease predictors and may, therefore, be driven by different pathophysiological mechanisms. If confirmed, such a finding will have important implications for future studies of visual symptoms and cognitive decline in PD and PD dementia. © 2011 Movement Disorder Society
AbstractList Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cognitive decline, visual impairment, and other visual symptoms remains poorly understood. Our aim was to characterize the spectrum of visual symptomatology in PD and examine clinical predictors for their occurrence. Sixty‐four subjects with PD, 26 with PD dementia, and 32 age‐matched controls were assessed for visual symptoms, cognitive impairment, and ocular pathology. Complex visual hallucinations were common in PD (17%) and PD dementia (89%). Dementia subjects reported illusions (65%) and presence (62%) more frequently than PD or control subjects, but the frequency of passage hallucinations in PD and PD dementia groups was equivalent (48% versus 69%, respectively; P = 0.102). Visual acuity and contrast sensitivity was impaired in parkinsonian subjects, with disease severity and age emerging as the key predictors. Regression analysis identified a variety of factors independently predictive of complex visual hallucinations (e.g., dementia, visual acuity, and depression), illusions (e.g., excessive daytime somnolence and disease severity), and presence (e.g., rapid eye movement sleep behavior disorder and excessive daytime somnolence). Our results demonstrate that different “hallucinatory” experiences in PD do not necessarily share common disease predictors and may, therefore, be driven by different pathophysiological mechanisms. If confirmed, such a finding will have important implications for future studies of visual symptoms and cognitive decline in PD and PD dementia. © 2011 Movement Disorder Society
Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cognitive decline, visual impairment, and other visual symptoms remains poorly understood. Our aim was to characterize the spectrum of visual symptomatology in PD and examine clinical predictors for their occurrence. Sixty‐four subjects with PD, 26 with PD dementia, and 32 age‐matched controls were assessed for visual symptoms, cognitive impairment, and ocular pathology. Complex visual hallucinations were common in PD (17%) and PD dementia (89%). Dementia subjects reported illusions (65%) and presence (62%) more frequently than PD or control subjects, but the frequency of passage hallucinations in PD and PD dementia groups was equivalent (48% versus 69%, respectively; P = 0.102). Visual acuity and contrast sensitivity was impaired in parkinsonian subjects, with disease severity and age emerging as the key predictors. Regression analysis identified a variety of factors independently predictive of complex visual hallucinations (e.g., dementia, visual acuity, and depression), illusions (e.g., excessive daytime somnolence and disease severity), and presence (e.g., rapid eye movement sleep behavior disorder and excessive daytime somnolence). Our results demonstrate that different “hallucinatory” experiences in PD do not necessarily share common disease predictors and may, therefore, be driven by different pathophysiological mechanisms. If confirmed, such a finding will have important implications for future studies of visual symptoms and cognitive decline in PD and PD dementia. © 2011 Movement Disorder Society
Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cognitive decline, visual impairment, and other visual symptoms remains poorly understood. Our aim was to characterize the spectrum of visual symptomatology in PD and examine clinical predictors for their occurrence. Sixty-four subjects with PD, 26 with PD dementia, and 32 age-matched controls were assessed for visual symptoms, cognitive impairment, and ocular pathology. Complex visual hallucinations were common in PD (17%) and PD dementia (89%). Dementia subjects reported illusions (65%) and presence (62%) more frequently than PD or control subjects, but the frequency of passage hallucinations in PD and PD dementia groups was equivalent (48% versus 69%, respectively; P = 0.102). Visual acuity and contrast sensitivity was impaired in parkinsonian subjects, with disease severity and age emerging as the key predictors. Regression analysis identified a variety of factors independently predictive of complex visual hallucinations (e.g., dementia, visual acuity, and depression), illusions (e.g., excessive daytime somnolence and disease severity), and presence (e.g., rapid eye movement sleep behavior disorder and excessive daytime somnolence). Our results demonstrate that different "hallucinatory" experiences in PD do not necessarily share common disease predictors and may, therefore, be driven by different pathophysiological mechanisms. If confirmed, such a finding will have important implications for future studies of visual symptoms and cognitive decline in PD and PD dementia.Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cognitive decline, visual impairment, and other visual symptoms remains poorly understood. Our aim was to characterize the spectrum of visual symptomatology in PD and examine clinical predictors for their occurrence. Sixty-four subjects with PD, 26 with PD dementia, and 32 age-matched controls were assessed for visual symptoms, cognitive impairment, and ocular pathology. Complex visual hallucinations were common in PD (17%) and PD dementia (89%). Dementia subjects reported illusions (65%) and presence (62%) more frequently than PD or control subjects, but the frequency of passage hallucinations in PD and PD dementia groups was equivalent (48% versus 69%, respectively; P = 0.102). Visual acuity and contrast sensitivity was impaired in parkinsonian subjects, with disease severity and age emerging as the key predictors. Regression analysis identified a variety of factors independently predictive of complex visual hallucinations (e.g., dementia, visual acuity, and depression), illusions (e.g., excessive daytime somnolence and disease severity), and presence (e.g., rapid eye movement sleep behavior disorder and excessive daytime somnolence). Our results demonstrate that different "hallucinatory" experiences in PD do not necessarily share common disease predictors and may, therefore, be driven by different pathophysiological mechanisms. If confirmed, such a finding will have important implications for future studies of visual symptoms and cognitive decline in PD and PD dementia.
Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cognitive decline, visual impairment, and other visual symptoms remains poorly understood. Our aim was to characterize the spectrum of visual symptomatology in PD and examine clinical predictors for their occurrence. Sixty-four subjects with PD, 26 with PD dementia, and 32 age-matched controls were assessed for visual symptoms, cognitive impairment, and ocular pathology. Complex visual hallucinations were common in PD (17%) and PD dementia (89%). Dementia subjects reported illusions (65%) and presence (62%) more frequently than PD or control subjects, but the frequency of passage hallucinations in PD and PD dementia groups was equivalent (48% versus 69%, respectively; P = 0.102). Visual acuity and contrast sensitivity was impaired in parkinsonian subjects, with disease severity and age emerging as the key predictors. Regression analysis identified a variety of factors independently predictive of complex visual hallucinations (e.g., dementia, visual acuity, and depression), illusions (e.g., excessive daytime somnolence and disease severity), and presence (e.g., rapid eye movement sleep behavior disorder and excessive daytime somnolence). Our results demonstrate that different "hallucinatory" experiences in PD do not necessarily share common disease predictors and may, therefore, be driven by different pathophysiological mechanisms. If confirmed, such a finding will have important implications for future studies of visual symptoms and cognitive decline in PD and PD dementia.
Author Burn, David J.
Archibald, Neil K.
Mosimann, Urs P.
Clarke, Mike P.
Author_xml – sequence: 1
  givenname: Neil K.
  surname: Archibald
  fullname: Archibald, Neil K.
  email: neilarchie@mac.com
  organization: Institute for Aging and Health, Newcastle University, Newcastle upon Tyne, United Kingdom
– sequence: 2
  givenname: Mike P.
  surname: Clarke
  fullname: Clarke, Mike P.
  organization: Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
– sequence: 3
  givenname: Urs P.
  surname: Mosimann
  fullname: Mosimann, Urs P.
  organization: Institute for Aging and Health, Newcastle University, Newcastle upon Tyne, United Kingdom
– sequence: 4
  givenname: David J.
  surname: Burn
  fullname: Burn, David J.
  organization: Institute for Aging and Health, Newcastle University, Newcastle upon Tyne, United Kingdom
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25262489$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21953737$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1v1DAQhi3Uim4LB_4AygVVHNL6I2M7R7TQBWlbvgpIXKxJ7EiGxNlmsqL77xvYXSqhchpp9DyvZvQes4PUp8DYM8HPBOfyvPN0JpUtxSM2E6BEbiWYAzbj1kKuhIUjdkz0g3MhQOjH7EiKEpRRZsYWXyOtsc1o063GvqMspuwDDj9joj6dUuYjBaSQYfIP7n3oQhojPmGHDbYUnu7mCfty8eZ6_jZfvl-8m79a5nUBVuSmBl5BI4rCatMEhAqQQ11okFgV6LU0Xk-nBYVGi6bxWpVYCBQGDPcVqBN2us1dDf3NOtDoukh1aFtMoV-TKzmUWkluJ_L5jlxXXfBuNcQOh43b_z4BL3YAUo1tM2CqI91zILUsbDlx51uuHnqiITSujiOOsU_jgLF1grvfLbipBfenhcl4-Y-xD32I3aX_im3Y_B90l68_7418a0Qaw-1fYyrH6ekvcN-uFu7i4_f5tfmk3VLdAfn2pCY
CitedBy_id crossref_primary_10_3233_JPD_213143
crossref_primary_10_1007_s00717_022_00516_x
crossref_primary_10_1016_j_ajpath_2024_01_017
crossref_primary_10_1017_cjn_2017_39
crossref_primary_10_1007_s00415_020_09925_x
crossref_primary_10_1186_s12916_018_1016_8
crossref_primary_10_2217_nmt_2016_0009
crossref_primary_10_3389_fnagi_2022_818597
crossref_primary_10_1024_1016_264X_a000399
crossref_primary_10_3758_s13423_016_1168_5
crossref_primary_10_1159_000514175
crossref_primary_10_1152_jn_00681_2017
crossref_primary_10_1007_s00415_022_11014_0
crossref_primary_10_4103_jcor_jcor_111_23
crossref_primary_10_1038_s41598_022_21847_4
crossref_primary_10_3233_JPD_191830
crossref_primary_10_1016_j_jocn_2017_02_033
crossref_primary_10_3233_JPD_150686
crossref_primary_10_1016_j_neubiorev_2016_01_002
crossref_primary_10_1002_mdc3_12821
crossref_primary_10_1002_mds_26533
crossref_primary_10_1016_j_jagp_2014_12_190
crossref_primary_10_1007_s00401_018_01956_z
crossref_primary_10_1016_j_visres_2015_08_011
crossref_primary_10_1176_appi_neurospych_17030063
crossref_primary_10_1212_WNL_0000000000006157
crossref_primary_10_1167_iovs_17_23230
crossref_primary_10_1016_j_parkreldis_2016_10_006
crossref_primary_10_1038_s41598_022_22037_y
crossref_primary_10_3389_fnins_2021_718820
crossref_primary_10_1016_j_jagp_2015_10_007
crossref_primary_10_1371_journal_pone_0275738
crossref_primary_10_1186_s40478_018_0596_z
crossref_primary_10_3389_fnins_2021_726476
crossref_primary_10_3389_fneur_2017_00206
crossref_primary_10_3389_fnins_2023_1205439
crossref_primary_10_1002_mds_27454
crossref_primary_10_1038_nrn_2017_62
crossref_primary_10_3238_PersNeuro_2016_09_16_01
crossref_primary_10_3390_diagnostics11122380
crossref_primary_10_1002_mds_28182
crossref_primary_10_1080_09286586_2024_2343725
crossref_primary_10_3390_neurolint15010012
crossref_primary_10_1109_RBME_2022_3161352
crossref_primary_10_1007_s10792_018_0934_y
crossref_primary_10_1016_j_psiq_2021_100347
crossref_primary_10_1038_eye_2012_205
crossref_primary_10_3390_vision2010002
crossref_primary_10_1093_texcom_tgab042
crossref_primary_10_1097_WNO_0000000000002235
crossref_primary_10_1007_s00415_020_10304_9
crossref_primary_10_3389_fnins_2020_567129
crossref_primary_10_1007_s00115_021_01165_2
crossref_primary_10_1007_s00415_018_9051_0
crossref_primary_10_1016_j_mehy_2020_110326
crossref_primary_10_1134_S0362119717080072
crossref_primary_10_1021_acschemneuro_8b00383
crossref_primary_10_31083_j_jin2301023
crossref_primary_10_1016_j_baga_2013_05_002
crossref_primary_10_1016_j_parkreldis_2018_05_023
crossref_primary_10_17116_jnevro2018118062105
crossref_primary_10_3390_jpm14030270
crossref_primary_10_3389_fnins_2021_799526
crossref_primary_10_1007_s00115_013_3754_3
crossref_primary_10_3390_proteomes10010004
crossref_primary_10_1136_jnnp_2016_314832
crossref_primary_10_1016_j_neulet_2014_04_027
crossref_primary_10_1016_j_bbr_2018_03_003
crossref_primary_10_1080_08820538_2021_1987482
crossref_primary_10_1016_j_arr_2023_101954
crossref_primary_10_1136_jnnp_2022_329342
crossref_primary_10_1016_j_parkreldis_2022_06_006
crossref_primary_10_3389_fneur_2020_533375
crossref_primary_10_1093_schbul_sbv073
crossref_primary_10_3233_JPD_223238
crossref_primary_10_3390_ijms24076363
crossref_primary_10_1002_cne_25481
crossref_primary_10_5498_wjp_v11_i8_491
crossref_primary_10_1016_j_gaitpost_2016_04_024
crossref_primary_10_1016_j_parkreldis_2024_107037
crossref_primary_10_1002_mds_27392
crossref_primary_10_1186_s12883_019_1365_8
crossref_primary_10_3233_JPD_202324
crossref_primary_10_3233_JAD_201516
crossref_primary_10_3390_biom14010073
crossref_primary_10_1038_nrneurol_2016_200
crossref_primary_10_1016_j_neucli_2021_03_005
crossref_primary_10_1016_j_parkreldis_2012_07_012
crossref_primary_10_1080_13546805_2021_1960812
crossref_primary_10_1212_WNL_0000000000006007
crossref_primary_10_1155_2020_2410863
crossref_primary_10_1016_j_parkreldis_2017_09_024
crossref_primary_10_1111_opo_12220
crossref_primary_10_1111_ane_13380
crossref_primary_10_1007_s00702_019_02097_7
crossref_primary_10_1002_gps_5950
crossref_primary_10_1177_08919887231195220
crossref_primary_10_1007_s11940_018_0519_0
crossref_primary_10_1186_1471_2458_14_815
crossref_primary_10_1111_psyg_12771
crossref_primary_10_1038_s41598_020_77833_1
crossref_primary_10_1093_brain_aww175
crossref_primary_10_3389_fnagi_2022_783634
crossref_primary_10_1080_01658107_2017_1305422
crossref_primary_10_1111_j_1755_3768_2012_02544_x
crossref_primary_10_1016_j_parkreldis_2012_05_016
crossref_primary_10_12659_MSM_890861
crossref_primary_10_1002_mdc3_12479
crossref_primary_10_1055_a_1210_7737
crossref_primary_10_1016_j_parkreldis_2017_09_015
crossref_primary_10_1016_j_neuropsychologia_2014_01_017
crossref_primary_10_1016_j_parkreldis_2017_02_014
crossref_primary_10_1212_WNL_0000000000009214
crossref_primary_10_1007_s40265_016_0600_5
crossref_primary_10_1097_HRP_0000000000000068
crossref_primary_10_3233_JPD_181523
crossref_primary_10_1038_nrneurol_2014_79
crossref_primary_10_1016_j_neuroscience_2013_09_013
crossref_primary_10_1155_2021_2704755
crossref_primary_10_1016_j_neubiorev_2023_105081
crossref_primary_10_1155_2020_3107185
crossref_primary_10_3389_fneur_2023_1158188
crossref_primary_10_1051_bioconf_20248601028
crossref_primary_10_1016_j_parkreldis_2015_08_031
crossref_primary_10_4103_0028_3886_349658
crossref_primary_10_1038_srep36284
crossref_primary_10_3233_JPD_202103
crossref_primary_10_1007_s40800_018_0082_3
crossref_primary_10_3109_02713683_2014_930154
crossref_primary_10_1097_WCO_0000000000000882
crossref_primary_10_1186_s40478_016_0334_3
crossref_primary_10_3233_JAD_180834
crossref_primary_10_1038_s41537_022_00237_9
crossref_primary_10_1080_08164622_2021_1984179
crossref_primary_10_3389_fnins_2019_00080
crossref_primary_10_1002_mds_25389
crossref_primary_10_1002_mds_25543
crossref_primary_10_1093_ageing_afaa043
crossref_primary_10_1007_s00415_019_09430_w
crossref_primary_10_1007_s00415_020_10094_0
crossref_primary_10_1055_a_2339_7375
crossref_primary_10_1093_brain_awac094
crossref_primary_10_7759_cureus_55436
crossref_primary_10_17116_jnevro201711791124_131
crossref_primary_10_1016_j_parkreldis_2013_12_009
crossref_primary_10_1024_1016_264X_a000402
crossref_primary_10_1002_mds_27557
crossref_primary_10_3390_ijms24054391
crossref_primary_10_1002_mdc3_12453
crossref_primary_10_1016_j_neurol_2019_11_002
crossref_primary_10_1016_j_parkreldis_2015_03_020
Cites_doi 10.1002/mds.20308
10.1093/brain/121.10.1819
10.1016/j.jns.2009.08.014
10.1007/s00415-0060-0254-4
10.1002/mds.21956
10.1017/S0140525X05000130
10.1093/brain/awp223
10.1002/mds.20582
10.1001/archneur.61.1.97
10.1002/mds.22829
10.1111/j.1600-0404.2007.00818.x
10.1177/089198879901200403
10.3928/0191-3913-19960501-04
10.1016/S0140-6736(96)90869-7
10.1212/01.WNL.0000103444.45882.D8
10.1002/gps.1965
10.1136/jnnp.55.3.181
10.1016/j.visres.2004.11.006
10.1016/0022-3956(75)90026-6
10.1001/archneurol.2009.221
10.1176/jnp.12.2.233
10.1002/mds.20844
10.1212/01.WNL.0000141853.27081.BD
10.1007/PL00007730
10.1192/bjp.169.4.459
10.1016/j.parkreldis.2010.01.003
10.1212/WNL.42.4.887
10.1001/archneur.1996.00550120077019
10.1177/0891988705284739
10.1002/mds.23429
10.1002/mds.10429
10.1093/brain/110.6.1675
10.1212/01.wnl.0000191565.11065.11
10.1001/archopht.119.7.1050
10.1002/mds.21507
10.1136/jnnp.63.4.434
10.1016/S0165-1781(00)00227-4
10.1002/mds.23411
10.1093/brain/123.4.733
10.1093/ageing/25.2.113
10.1016/S1353-8020(99)00062-0
10.1136/jnnp.51.11.1401
10.1212/WNL.0b013e3181fd6158
ContentType Journal Article
Copyright Copyright © 2011 Movement Disorder Society
2015 INIST-CNRS
Copyright © 2011 Movement Disorder Society.
Copyright_xml – notice: Copyright © 2011 Movement Disorder Society
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 Movement Disorder Society.
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/mds.23891
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8257
EndPage 2395
ExternalDocumentID 21953737
25262489
10_1002_mds_23891
MDS23891
ark_67375_WNG_FQZCT7R6_L
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Parkinson's UK
  grantid: F-0701
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
XG1
XV2
ZGI
ZZTAW
~IA
~WT
AAHHS
AAYXX
ACCFJ
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4581-7c50b5f144867fea5b5a05c4652ab4ad627d6537e3a761ffd639a41a17570db53
IEDL.DBID DR2
ISSN 0885-3185
1531-8257
IngestDate Thu Jul 10 18:11:52 EDT 2025
Mon Jul 21 06:03:07 EDT 2025
Mon Jul 21 09:17:24 EDT 2025
Tue Jul 01 01:44:12 EDT 2025
Thu Apr 24 22:56:09 EDT 2025
Sun Sep 21 06:20:21 EDT 2025
Sun Sep 21 06:20:05 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 13
Keywords Nervous system diseases
complex visual hallucinations
Parkinson's disease
Parkinson's disease dementia
Parkinson disease
Visual acuity
Visual hallucination
contrast sensitivity
Cerebral disorder
Sensitivity
Central nervous system disease
Degenerative disease
Extrapyramidal syndrome
Dementia
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
Copyright © 2011 Movement Disorder Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4581-7c50b5f144867fea5b5a05c4652ab4ad627d6537e3a761ffd639a41a17570db53
Notes Full financial disclosures and author roles may be found in the online version of this article.
Relevant conflicts of interest/financial disclosures: Nothing to report.
ArticleID:MDS23891
Funding agencies: N.K.A. was funded by Parkinson's UK for this work. We acknowledge support from the UK NIHR Biomedical Research Center for Aging and Age-Related Disease award to the Newcastle upon Tyne Hospitals NHS Foundation Trust.
istex:148FC0A3A8EAF6B5B722AA70A0BC42F1F5597F08
ark:/67375/WNG-FQZCT7R6-L
Nothing to report.
Relevant conflicts of interest/financial disclosures
Funding agencies
N.K.A. was funded by Parkinson's UK for this work. We acknowledge support from the UK NIHR Biomedical Research Center for Aging and Age‐Related Disease award to the Newcastle upon Tyne Hospitals NHS Foundation Trust.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 21953737
PQID 905963208
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_905963208
pubmed_primary_21953737
pascalfrancis_primary_25262489
crossref_citationtrail_10_1002_mds_23891
crossref_primary_10_1002_mds_23891
wiley_primary_10_1002_mds_23891_MDS23891
istex_primary_ark_67375_WNG_FQZCT7R6_L
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2011
PublicationDateYYYYMMDD 2011-11-01
PublicationDate_xml – month: 11
  year: 2011
  text: November 2011
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Hoboken, NJ
– name: United States
PublicationTitle Movement disorders
PublicationTitleAlternate Mov. Disord
PublicationYear 2011
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley
References Newman EJ, Breen K, Patterson J, Hadley DM, Grosset KA, Grosset DG. Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord 2009; 24: 2379-2385.
Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing 1996; 25: 113-120.
Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996; 53: 1265-1268.
Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-707; quiz, 1837.
Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102.
Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, Van Laar T. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 2009; 132: 2980-2993.
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005; 28: 737-757; discussion 757-794.
Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998; 21: 289-295.
Brown GG, Rahill AA, Gorell JM, et al. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol 1999; 12: 180-188.
Castelo-Branco M, Mendes M, Silva F, et al. Motion integration deficits are independent of magnocelluar impairment in Parkinson's disease. Neuropsychologia 2008. doi: 10.1016/j.neuropsychologia.2008.09.003.
Koerts J, Borg M, Meppelink AM, Leenders KL, Beilen M, van Laar T. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations. Parkinsonism Relat Disord 2010; 16: 270-274.
Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992; 42: 887-890.
Brodsky MA, Godbold J, Roth T, Olanow CW. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003; 18: 668-672.
Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson's disease.[see comment]. Neurology 2004; 62: 177-180.
Lo RY, Tanner CM, Albers KB, et al. Clinical features in early Parkinson disease and survival. Arch Neurol 2009; 66: 1353-1358.
Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006; 21: 916-923.
Benke T. Peduncular hallucinosis: a syndrome of impaired reality monitoring. J Neurol 2006; 253: 1561-1571.
Davidsdottir S, Cronin-Golomb A, Lee A. Visual and spatial symptoms in Parkinson's disease. Vision Res 2005; 45: 1285-1296.
Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119: 1050-1058.
Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000; 97: 153-164.
Graham JM, Grunewald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 63: 434-440.
Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology, and risk factors. Brain 2000; 123: 733-745.
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
Levin BE, Llabre MM, Weiner WJ. Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 1988; 51: 1401-1404.
Goetz CG, Ouyang B, Negron A, Stebbins GT. Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study. Neurology 2010; 75: 1773-1779.
Fenelon G, Alves G. Epidemiology of psychosis in Parkinson's disease. J Neurol Sci 2010; 289: 12-17.
Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12: 233-239.
Repka MX, Claro MC, Loupe DN, Reich SG. Ocular motility in Parkinson's disease. J Pediatr Ophthalmol Strabismus 1996; 33: 144-147.
Onofrj M, Thomas A, D'Andreamatteo G, et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurolog Sci 2002; 23( Suppl 2): S91-S94.
Stebbins GT, Goetz CG, Carrillo MC, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004; 63: 1409-1416.
Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease without dementia. Neurology 2005; 65: 1907-1913.
Pacchetti C, Manni R, Zangaglia R, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 2005; 20: 1439-1448.
Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome [see comment]. Lancet 1996; 347: 794-797.
Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169: 459-467.
Fenelon G, Soulas T, Cleret de Langavant L, Trinkler I, Bachoud-Lévi C. Feeling of a presence in PD. J Neurol Neurosurg Psychiatry (in press).
Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 2005; 20: 130-140.
Matsui H, Udaka F, Tamura A, et al. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J Ger Psychiatry Neurol 2006; 19: 36-40.
Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998; 121: 1819-1840.
Bodis-Wollner I, Marx M, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Brain 1987; 110: 1675-1698.
Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000; 6: 165-170.
Mosimann UP, Collerton D, Dudley R, et al. A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry 2008; 23: 712-718.
Boeve BF, Silber MH, Ferman TJ, Smith GE, Petersen RC. Validation of a questionnaire for the diagnosis of REM sleep behavior disorder. Neurology 2002; 58: A509.
Llebaria G, Pagonabarraga J, Martinez-Corral M, et al. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease. Mov Disord 2010; 25: 2785-2791.
Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation, and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245( Suppl 1): S10-S14.
2009; 66
2002; 58
2004; 63
2010; 75
2009; 24
2004; 61
2010; 16
2004; 62
2000; 6
1997; 63
2010; 289
2009; 132
2008
1975; 12
2006; 253
2005; 20
2006; 19
2005; 65
1988; 51
2003; 18
1996; 169
1998; 21
1992; 55
2005; 28
2005; 45
1996; 53
1996; 33
1996; 347
2010; 25
1987; 110
2006; 21
2000; 12
2002; 23
2000; 97
1987
1999; 12
2008; 23
2000; 123
1992; 42
1996; 25
2001; 119
1998; 121
2007; 22
1998; 245
Onofrj M (e_1_2_6_41_2) 2002; 23
Fenelon G (e_1_2_6_10_2)
e_1_2_6_31_2
e_1_2_6_30_2
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_12_2
e_1_2_6_35_2
e_1_2_6_13_2
e_1_2_6_33_2
e_1_2_6_11_2
Castelo‐Branco M (e_1_2_6_15_2) 2008
e_1_2_6_32_2
e_1_2_6_39_2
e_1_2_6_17_2
e_1_2_6_38_2
e_1_2_6_14_2
e_1_2_6_37_2
e_1_2_6_36_2
e_1_2_6_42_2
e_1_2_6_20_2
Diederich NJ (e_1_2_6_16_2) 1998; 21
e_1_2_6_40_2
Boeve BF (e_1_2_6_25_2) 2002; 58
Repka MX (e_1_2_6_34_2) 1996; 33
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_47_2
e_1_2_6_23_2
e_1_2_6_48_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_49_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_43_2
e_1_2_6_27_2
e_1_2_6_44_2
e_1_2_6_26_2
e_1_2_6_45_2
e_1_2_6_46_2
References_xml – reference: Repka MX, Claro MC, Loupe DN, Reich SG. Ocular motility in Parkinson's disease. J Pediatr Ophthalmol Strabismus 1996; 33: 144-147.
– reference: Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
– reference: Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology, and risk factors. Brain 2000; 123: 733-745.
– reference: Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998; 121: 1819-1840.
– reference: Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998; 21: 289-295.
– reference: Onofrj M, Thomas A, D'Andreamatteo G, et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurolog Sci 2002; 23( Suppl 2): S91-S94.
– reference: Koerts J, Borg M, Meppelink AM, Leenders KL, Beilen M, van Laar T. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations. Parkinsonism Relat Disord 2010; 16: 270-274.
– reference: Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000; 6: 165-170.
– reference: Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169: 459-467.
– reference: Goetz CG, Ouyang B, Negron A, Stebbins GT. Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study. Neurology 2010; 75: 1773-1779.
– reference: Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 2005; 20: 130-140.
– reference: Castelo-Branco M, Mendes M, Silva F, et al. Motion integration deficits are independent of magnocelluar impairment in Parkinson's disease. Neuropsychologia 2008. doi: 10.1016/j.neuropsychologia.2008.09.003.
– reference: Matsui H, Udaka F, Tamura A, et al. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J Ger Psychiatry Neurol 2006; 19: 36-40.
– reference: Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653.
– reference: Benke T. Peduncular hallucinosis: a syndrome of impaired reality monitoring. J Neurol 2006; 253: 1561-1571.
– reference: Brown GG, Rahill AA, Gorell JM, et al. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol 1999; 12: 180-188.
– reference: Graham JM, Grunewald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 63: 434-440.
– reference: Fenelon G, Alves G. Epidemiology of psychosis in Parkinson's disease. J Neurol Sci 2010; 289: 12-17.
– reference: Boeve BF, Silber MH, Ferman TJ, Smith GE, Petersen RC. Validation of a questionnaire for the diagnosis of REM sleep behavior disorder. Neurology 2002; 58: A509.
– reference: Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
– reference: Mosimann UP, Collerton D, Dudley R, et al. A semi-structured interview to assess visual hallucinations in older people. Int J Geriatr Psychiatry 2008; 23: 712-718.
– reference: Llebaria G, Pagonabarraga J, Martinez-Corral M, et al. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease. Mov Disord 2010; 25: 2785-2791.
– reference: Bodis-Wollner I, Marx M, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson's disease. Brain 1987; 110: 1675-1698.
– reference: Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
– reference: Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation, and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998; 245( Suppl 1): S10-S14.
– reference: Davidsdottir S, Cronin-Golomb A, Lee A. Visual and spatial symptoms in Parkinson's disease. Vision Res 2005; 45: 1285-1296.
– reference: Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006; 21: 916-923.
– reference: Ohayon MM. Prevalence of hallucinations and their pathological associations in the general population. Psychiatry Res 2000; 97: 153-164.
– reference: Brodsky MA, Godbold J, Roth T, Olanow CW. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003; 18: 668-672.
– reference: Lo RY, Tanner CM, Albers KB, et al. Clinical features in early Parkinson disease and survival. Arch Neurol 2009; 66: 1353-1358.
– reference: Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, Van Laar T. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 2009; 132: 2980-2993.
– reference: Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12: 233-239.
– reference: Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992; 42: 887-890.
– reference: Stebbins GT, Goetz CG, Carrillo MC, et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004; 63: 1409-1416.
– reference: Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-707; quiz, 1837.
– reference: Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing 1996; 25: 113-120.
– reference: Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome [see comment]. Lancet 1996; 347: 794-797.
– reference: Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson's disease.[see comment]. Neurology 2004; 62: 177-180.
– reference: Levin BE, Llabre MM, Weiner WJ. Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 1988; 51: 1401-1404.
– reference: Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102.
– reference: Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119: 1050-1058.
– reference: Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996; 53: 1265-1268.
– reference: Newman EJ, Breen K, Patterson J, Hadley DM, Grosset KA, Grosset DG. Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord 2009; 24: 2379-2385.
– reference: Fenelon G, Soulas T, Cleret de Langavant L, Trinkler I, Bachoud-Lévi C. Feeling of a presence in PD. J Neurol Neurosurg Psychiatry (in press).
– reference: Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease without dementia. Neurology 2005; 65: 1907-1913.
– reference: Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci 2005; 28: 737-757; discussion 757-794.
– reference: Pacchetti C, Manni R, Zangaglia R, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 2005; 20: 1439-1448.
– volume: 169
  start-page: 459
  year: 1996
  end-page: 467
  article-title: Hypnagogic and hypnopompic hallucinations: pathological phenomena?
  publication-title: Br J Psychiatry
– volume: 51
  start-page: 1401
  year: 1988
  end-page: 1404
  article-title: Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 23
  start-page: 712
  year: 2008
  end-page: 718
  article-title: A semi‐structured interview to assess visual hallucinations in older people
  publication-title: Int J Geriatr Psychiatry
– volume: 75
  start-page: 1773
  year: 2010
  end-page: 1779
  article-title: Hallucinations and sleep disorders in PD: ten‐year prospective longitudinal study
  publication-title: Neurology
– volume: 123
  start-page: 733
  year: 2000
  end-page: 745
  article-title: Hallucinations in Parkinson's disease: prevalence, phenomenology, and risk factors
  publication-title: Brain
– volume: 63
  start-page: 434
  year: 1997
  end-page: 440
  article-title: Hallucinosis in idiopathic Parkinson's disease
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 97
  start-page: 153
  year: 2000
  end-page: 164
  article-title: Prevalence of hallucinations and their pathological associations in the general population
  publication-title: Psychiatry Res
– volume: 12
  start-page: 180
  year: 1999
  end-page: 188
  article-title: Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease
  publication-title: J Geriatr Psychiatry Neurol
– volume: 21
  start-page: 916
  year: 2006
  end-page: 923
  article-title: International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study
  publication-title: Mov Disord
– volume: 42
  start-page: 887
  year: 1992
  end-page: 890
  article-title: Abnormalities in color vision and contrast sensitivity in Parkinson's disease
  publication-title: Neurology
– year: 2008
  article-title: Motion integration deficits are independent of magnocelluar impairment in Parkinson's disease
  publication-title: Neuropsychologia
– volume: 6
  start-page: 165
  year: 2000
  end-page: 170
  article-title: Construction of freezing of gait questionnaire for patients with Parkinsonism
  publication-title: Parkinsonism Relat Disord
– volume: 347
  start-page: 794
  year: 1996
  end-page: 797
  article-title: Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome [see comment]
  publication-title: Lancet
– volume: 45
  start-page: 1285
  year: 2005
  end-page: 1296
  article-title: Visual and spatial symptoms in Parkinson's disease
  publication-title: Vision Res
– volume: 19
  start-page: 36
  year: 2006
  end-page: 40
  article-title: Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease
  publication-title: J Ger Psychiatry Neurol
– volume: 20
  start-page: 130
  year: 2005
  end-page: 140
  article-title: Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model
  publication-title: Mov Disord
– volume: 63
  start-page: 1409
  year: 2004
  end-page: 1416
  article-title: Altered cortical visual processing in PD with hallucinations: an fMRI study
  publication-title: Neurology
– volume: 62
  start-page: 177
  year: 2004
  end-page: 180
  article-title: Ophthalmologic features of Parkinson's disease.[see comment]
  publication-title: Neurology
– start-page: 153
  year: 1987
  end-page: 163
– volume: 23
  issue: Suppl 2
  year: 2002
  end-page: S94
  article-title: Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8‐year follow‐up
  publication-title: Neurolog Sci
– volume: 28
  start-page: 737
  year: 2005
  end-page: 757
  article-title: Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations
  publication-title: Behav Brain Sci
– volume: 110
  start-page: 1675
  year: 1987
  end-page: 1698
  article-title: Visual dysfunction in Parkinson's disease
  publication-title: Brain
– volume: 12
  start-page: 233
  year: 2000
  end-page: 239
  article-title: Validation of the NPI‐Q, a brief clinical form of the Neuropsychiatric Inventory
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 25
  start-page: 2785
  year: 2010
  end-page: 2791
  article-title: Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease
  publication-title: Mov Disord
– volume: 55
  start-page: 181
  year: 1992
  end-page: 184
  article-title: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico‐pathological study of 100 cases
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 12
  start-page: 189
  year: 1975
  end-page: 198
  article-title: “Mini‐mental state.” A practical method for grading the cognitive state of patients for the clinician
  publication-title: J Psychiatr Res
– volume: 23
  start-page: 837
  year: 2008
  end-page: 844
  article-title: The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years
  publication-title: Mov Disord
– volume: 132
  start-page: 2980
  year: 2009
  end-page: 2993
  article-title: Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations
  publication-title: Brain
– volume: 21
  start-page: 289
  year: 1998
  end-page: 295
  article-title: Poor visual discrimination and visual hallucinations in Parkinson's disease
  publication-title: Clin Neuropharmacol
– volume: 66
  start-page: 1353
  year: 2009
  end-page: 1358
  article-title: Clinical features in early Parkinson disease and survival
  publication-title: Arch Neurol
– volume: 58
  start-page: A509
  year: 2002
  article-title: Validation of a questionnaire for the diagnosis of REM sleep behavior disorder
  publication-title: Neurology
– volume: 53
  start-page: 1265
  year: 1996
  end-page: 1268
  article-title: Visual hallucinations associated with Parkinson disease
  publication-title: Arch Neurol
– volume: 16
  start-page: 270
  year: 2010
  end-page: 274
  article-title: Attentional and perceptual impairments in Parkinson's disease with visual hallucinations
  publication-title: Parkinsonism Relat Disord
– volume: 24
  start-page: 2379
  year: 2009
  end-page: 2385
  article-title: Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland
  publication-title: Mov Disord
– volume: 245
  start-page: S10
  issue: Suppl 1
  year: 1998
  end-page: S14
  article-title: PDQ‐39: a review of the development, validation, and application of a Parkinson's disease quality of life questionnaire and its associated measures
  publication-title: J Neurol
– volume: 253
  start-page: 1561
  year: 2006
  end-page: 1571
  article-title: Peduncular hallucinosis: a syndrome of impaired reality monitoring
  publication-title: J Neurol
– volume: 20
  start-page: 1439
  year: 2005
  end-page: 1448
  article-title: Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease
  publication-title: Mov Disord
– volume: 33
  start-page: 144
  year: 1996
  end-page: 147
  article-title: Ocular motility in Parkinson's disease
  publication-title: J Pediatr Ophthalmol Strabismus
– volume: 61
  start-page: 97
  year: 2004
  end-page: 102
  article-title: Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists
  publication-title: Arch Neurol
– volume: 119
  start-page: 1050
  year: 2001
  end-page: 1058
  article-title: Development of the 25‐item National Eye Institute Visual Function Questionnaire
  publication-title: Arch Ophthalmol
– volume: 25
  start-page: 113
  year: 1996
  end-page: 120
  article-title: Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale
  publication-title: Age Ageing
– volume: 65
  start-page: 1907
  year: 2005
  end-page: 1913
  article-title: Visual dysfunction in Parkinson disease without dementia
  publication-title: Neurology
– volume: 18
  start-page: 668
  year: 2003
  end-page: 672
  article-title: Sleepiness in Parkinson's disease: a controlled study
  publication-title: Mov Disord
– volume: 25
  start-page: 2649
  year: 2010
  end-page: 2653
  article-title: Systematic review of levodopa dose equivalency reporting in Parkinson's disease
  publication-title: Mov Disord
– volume: 121
  start-page: 1819
  year: 1998
  end-page: 1840
  article-title: Complex visual hallucinations. Clinical and neurobiological insights
  publication-title: Brain
– volume: 289
  start-page: 12
  year: 2010
  end-page: 17
  article-title: Epidemiology of psychosis in Parkinson's disease
  publication-title: J Neurol Sci
– article-title: Feeling of a presence in PD
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 22
  start-page: 1689
  year: 2007
  end-page: 707
  article-title: Clinical diagnostic criteria for dementia associated with Parkinson's disease
  publication-title: Mov Disord
– ident: e_1_2_6_44_2
  doi: 10.1002/mds.20308
– ident: e_1_2_6_7_2
  doi: 10.1093/brain/121.10.1819
– ident: e_1_2_6_38_2
  doi: 10.1016/j.jns.2009.08.014
– ident: e_1_2_6_6_2
  doi: 10.1007/s00415-0060-0254-4
– ident: e_1_2_6_39_2
  doi: 10.1002/mds.21956
– ident: e_1_2_6_43_2
  doi: 10.1017/S0140525X05000130
– ident: e_1_2_6_46_2
  doi: 10.1093/brain/awp223
– ident: e_1_2_6_8_2
  doi: 10.1002/mds.20582
– ident: e_1_2_6_26_2
  doi: 10.1001/archneur.61.1.97
– ident: e_1_2_6_49_2
  doi: 10.1002/mds.22829
– ident: e_1_2_6_20_2
  doi: 10.1111/j.1600-0404.2007.00818.x
– ident: e_1_2_6_33_2
  doi: 10.1177/089198879901200403
– volume: 33
  start-page: 144
  year: 1996
  ident: e_1_2_6_34_2
  article-title: Ocular motility in Parkinson's disease
  publication-title: J Pediatr Ophthalmol Strabismus
  doi: 10.3928/0191-3913-19960501-04
– ident: e_1_2_6_40_2
  doi: 10.1016/S0140-6736(96)90869-7
– ident: e_1_2_6_2_2
  doi: 10.1212/01.WNL.0000103444.45882.D8
– ident: e_1_2_6_29_2
  doi: 10.1002/gps.1965
– ident: e_1_2_6_17_2
  doi: 10.1136/jnnp.55.3.181
– ident: e_1_2_6_31_2
  doi: 10.1016/j.visres.2004.11.006
– volume: 23
  issue: 2
  year: 2002
  ident: e_1_2_6_41_2
  article-title: Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8‐year follow‐up
  publication-title: Neurolog Sci
– ident: e_1_2_6_32_2
  doi: 10.1016/0022-3956(75)90026-6
– ident: e_1_2_6_48_2
  doi: 10.1001/archneurol.2009.221
– ident: e_1_2_6_24_2
  doi: 10.1176/jnp.12.2.233
– ident: e_1_2_6_3_2
  doi: 10.1002/mds.20844
– year: 2008
  ident: e_1_2_6_15_2
  article-title: Motion integration deficits are independent of magnocelluar impairment in Parkinson's disease
  publication-title: Neuropsychologia
– ident: e_1_2_6_47_2
  doi: 10.1212/01.WNL.0000141853.27081.BD
– ident: e_1_2_6_22_2
  doi: 10.1007/PL00007730
– ident: e_1_2_6_35_2
  doi: 10.1192/bjp.169.4.459
– ident: e_1_2_6_45_2
  doi: 10.1016/j.parkreldis.2010.01.003
– ident: e_1_2_6_14_2
  doi: 10.1212/WNL.42.4.887
– volume: 21
  start-page: 289
  year: 1998
  ident: e_1_2_6_16_2
  article-title: Poor visual discrimination and visual hallucinations in Parkinson's disease
  publication-title: Clin Neuropharmacol
– ident: e_1_2_6_37_2
  doi: 10.1001/archneur.1996.00550120077019
– ident: e_1_2_6_11_2
  doi: 10.1177/0891988705284739
– ident: e_1_2_6_28_2
  doi: 10.1002/mds.23429
– ident: e_1_2_6_27_2
  doi: 10.1002/mds.10429
– ident: e_1_2_6_12_2
  doi: 10.1093/brain/110.6.1675
– ident: e_1_2_6_10_2
  article-title: Feeling of a presence in PD
  publication-title: J Neurol Neurosurg Psychiatry
– ident: e_1_2_6_13_2
  doi: 10.1212/01.wnl.0000191565.11065.11
– ident: e_1_2_6_30_2
  doi: 10.1001/archopht.119.7.1050
– ident: e_1_2_6_18_2
  doi: 10.1002/mds.21507
– ident: e_1_2_6_36_2
  doi: 10.1136/jnnp.63.4.434
– ident: e_1_2_6_5_2
  doi: 10.1016/S0165-1781(00)00227-4
– ident: e_1_2_6_9_2
  doi: 10.1002/mds.23411
– volume: 58
  start-page: A509
  year: 2002
  ident: e_1_2_6_25_2
  article-title: Validation of a questionnaire for the diagnosis of REM sleep behavior disorder
  publication-title: Neurology
– ident: e_1_2_6_4_2
  doi: 10.1093/brain/123.4.733
– ident: e_1_2_6_19_2
  doi: 10.1093/ageing/25.2.113
– ident: e_1_2_6_21_2
  doi: 10.1016/S1353-8020(99)00062-0
– ident: e_1_2_6_23_2
  doi: 10.1136/jnnp.51.11.1401
– ident: e_1_2_6_42_2
  doi: 10.1212/WNL.0b013e3181fd6158
SSID ssj0011516
Score 2.4429717
Snippet Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2387
SubjectTerms Aged
Biological and medical sciences
Cognition Disorders - diagnosis
Cognition Disorders - physiopathology
complex visual hallucinations
contrast sensitivity
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dementia - diagnosis
Dementia - physiopathology
Female
Hallucinations - diagnosis
Hallucinations - physiopathology
Humans
Male
Medical sciences
Neurology
Neuropsychological Tests
Parkinson Disease - diagnosis
Parkinson Disease - physiopathology
Parkinson's disease
Parkinson's disease dementia
Psychiatric Status Rating Scales
Severity of Illness Index
Vision Disorders - diagnosis
Vision Disorders - physiopathology
visual acuity
Title Visual symptoms in Parkinson's disease and Parkinson's disease dementia
URI https://api.istex.fr/ark:/67375/WNG-FQZCT7R6-L/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.23891
https://www.ncbi.nlm.nih.gov/pubmed/21953737
https://www.proquest.com/docview/905963208
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rS9xAEB9EofRLa2sfUSuhiO2XnMlmX6GfivaU4gm12kopLPsKHHo5MXeg_eu7u3nIlSuUQj6EMEsyMzu7k52Z3wDsGoO1hyZKeKZVgiUqEkmRTpjPpiptqXLji5NHp_T4An--JJcr8KGrhWnwIfoDN28ZYb32Bi5Vvf8AGjox9QD5KJtbf7Ocetz8w7MeOso5OqHtqTMiEiqEO1ShFO33Ixf2ojUv1jufGylrJ56y6WuxzPFc9GPDRjR8Cj87Fpr8k6vBfKYG-tcf6I7_yeM6PGkd1PhjM6OewYqtnsOjURuC34Cjb-N67gjq-8nNbDqp43EV-9LpUEX2ro7biE8sK7P0uQnnkWP5Ai6Gn84PjpO2G0OiMeFZwjRJFSndDxinrLSSKCJTojElSCosDUXMUJIzm0tGs7I0zveROJPOP2GpUSR_CavVtLKvIUZcY46R4thdxGIlkcpKyS2XhSpYHsH7Ti9Ct1DlvmPGtWhAlpFwghFBMBG87UlvGnyOZUR7Qbk9hePeJ7QxIr6fHonhlx8H5-yMipMIdha03w9ABFGEeRFB3E0H4ezQB1dkZafzWhS-j1GOUh7Bq2aaPAz2oUr3NsdWUPbfP1SMDr-Gm81_J92Cx-GcO9RHbsPq7HZu3zhHaaZ2gkX8Bop4DSQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ri9NAEB_OO1C_-H7ExxlE1C_pJZt9Bfwip72qbcGzp4cgy74CRZsepgX1r3d38zgqFUTIhxBmSWZmJ5nM4zcAT4zB2kMTJTzTKsESFYmkSCfMV1OVtlS58c3JkykdneC3p-R0B150vTANPkQfcPOWEd7X3sB9QPrgHDV0YeoB8mm2C7AX8nPeJTruwaOcqxMGnzozIqFHuMMVStFBv3Tja7TnBfvDV0fK2gmobCZbbHM9Nz3Z8CkaXoUvHRNNBcrXwXqlBvrXH_iO_8vlNbjS-qjxy2ZTXYcdW92Ai5M2C38Tjj7O67UjqH8uzlbLRR3Pq9h3T4dGsmd13CZ9YlmZrddNCEnO5S04Gb6eHY6SdiBDojHhWcI0SRUp3T8Yp6y0kigiU6IxJUgqLA1FzFCSM5tLRrOyNM79kTiTzkVhqVEkvw271bKydyFGXGOOkeLYHcRiJZHKSsktl4UqWB7B804xQrdo5X5oxjfR4Cwj4QQjgmAieNyTnjUQHduIngbt9hSOe1_Txoj4ND0Sw_efD2fsmIpxBPsb6u8XIIIowryIIO72g3Cm6PMrsrLLdS0KP8ooRymP4E6zT84X-2ylu5tjK2j77w8qJq8-hJN7_076CC6NZpOxGL-ZvrsPl0PYO7RLPoDd1fe1fej8ppXaD-bxG1edEUI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEB9qC8Uv9a3xUYOI-iXXZLOv4CdpvVbtHVpbLSIs-woc9XKHuQP1r3d38ygnJ4iQDyHMcjczO9lfdnZ-A_DUGKw9NVHCM60SLFGRSIp0wvxpqtKWKje-OHk0pkdn-O05Od-Al10tTMMP0W-4-cgI72sf4HNT7l2Shk5NPUA-y3YFtjB1y6RHRCc9d5RDOqHvqYsiEkqEO1qhFO31Q1cWoy1v1x_-cKSsnX3KprHFOuS5CmTDSjS8Bl87HZoDKBeD5UIN9K8_6B3_U8nrsNMi1PhVM6VuwIatbsL2qM3B34LDT5N66QTqn9P5Yjat40kV-9rpUEb2vI7blE8sK7P2uQkbkhN5G86Gr0_3j5K2HUOiMeFZwjRJFSndFxinrLSSKCJTojElSCosDUXMUJIzm0tGs7I0DvxInEkHUFhqFMnvwGY1q-w9iBHXmGOkOHYXsVhJpLJScstloQqWR_Ci84vQLVe5b5nxTTQsy0g4w4hgmAie9KLzhqBjndCz4NxewmnvT7QxIj6PD8Xww5f9U3ZCxXEEuyve7wcggijCvIgg7qaDcIHosyuysrNlLQrfyChHKY_gbjNNLgf7XKX7NadWcPbf_6gYHXwMN_f_XfQxbL8_GIrjN-N3D-Bq2PMOtZIPYXPxfWkfOdC0ULshOH4DGZwP8Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Visual+symptoms+in+Parkinson%27s+disease+and+Parkinson%27s+disease+dementia&rft.jtitle=Movement+disorders&rft.au=Archibald%2C+Neil+K.&rft.au=Clarke%2C+Mike+P.&rft.au=Mosimann%2C+Urs+P.&rft.au=Burn%2C+David+J.&rft.date=2011-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=26&rft.issue=13&rft.spage=2387&rft.epage=2395&rft_id=info:doi/10.1002%2Fmds.23891&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_FQZCT7R6_L
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon